Company profile for ImmunoPrecise

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ImmunoPrecise is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific program- platforms that blend seamlessly with IPA’s Artemis Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional algorithmic outputs in therap...
ImmunoPrecise is a full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell interrogation technology, DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific program- platforms that blend seamlessly with IPA’s Artemis Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional algorithmic outputs in therapeutic optimization, stability, affinity and manufacturability.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4837 Amber Valley Parkway Suite 11 Fargo, ND 58104, USA
Telephone
Telephone
+1 (701) 353-0022
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/marketing/immunoprecise-evolves-mindwalk-reflect-ai-focused-future

FIERCE PHARMA
04 Sep 2025

https://www.businesswire.com/news/home/20250827492115/en/ImmunoPrecise-Advances-AI-Discovered-and-Developed-Universal-Dengue-Vaccine-Initiative-Moves-into-Preclinical-Antibody-Generation

BUSINESSWIRE
27 Aug 2025

https://www.businesswire.com/news/home/20250806282998/en/ImmunoPrecise-Antibodies-Ltd.-Divests-Netherlands-Facilities-to-AVS-Bio-to-Accelerate-Bio-Native-AI-Innovation

BUSINESSWIRE
06 Aug 2025

https://www.businesswire.com/news/home/20250729317438/en/ImmunoPrecise-Antibodies-IPA-Reports-Full-Fiscal-Year-2025-Results-Record-Fourth-Quarter-Revenue-and-Record-Fourth-Quarter-Adjusted-EBITDA

BUSINESSWIRE
29 Jul 2025

https://www.businesswire.com/news/home/20250721352737/en/ImmunoPrecise-Appoints-Healthcare-Data-Visionary-Jeff-Fried-to-Advisory-Board

BUSINESSWIRE
21 Jul 2025

https://www.businesswire.com/news/home/20250714543066/en/ImmunoPrecise-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement

BUSINESSWIRE
14 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty